THERAPEUTIC INDICATIONS: ONCOVET® IM cream is indicated for topical treatment in immunocompetent canines and felines with actinic keratosis, squamous cell carcinoma, melanoma, photoinduced cutaneous hemangioma and viral papillomas.
Pharmacodynamic properties: Imiquimod is a chemotherapy for topical use, antiviral. Imiquimod is an immunomodulatory synthetic imidazoquinoline amine effective for the topical treatment of different dermatological conditions.
Imiquimod is an immune response modifier. Saturable binding studies suggest that there is a membrane receptor for imiquimod on sensitive immune cells. Imiquimod does not have direct antiviral
activity. In animal models, imiquimod is effective against viral infections and acts as an antitumor agent, mainly through the induction of interferon alfa and other cytokines.
Induction in the innate immune system has also been shown in clinical trials and induces local responses of interferons α, β and γ, and tumor necrosis factor-α, and interleukins 1, 6, 8, 10 and 12 after application. of imiquimod cream. An increase in systemic levels of interferon alfa and other cytokines has been observed in a pharmacokinetic study after topical application of imiquimod.
Exclusive use in Veterinary Medicine.
Sale with Filed Veterinary Prescription (Cat. II).
Use in Canines and Felines.
Made in Argentina.
The containers used must be discarded in accordance with current local legislation.
Store at temperatures between 15 and 30ºC